Suggestions
Chris Armstrong
Preclinical in vivo software CEO at Overwatch Research
Professional Background
Chris Armstrong is a distinguished professional in the field of biomedical research and technology, currently serving as the Co-Founder and CEO of Overwatch Research. With a passionate commitment to improving the accuracy and efficiency of pre-clinical medical research, Chris's company focuses on developing innovative software solutions designed to accelerate research processes and virtually eliminate errors that can undermine scientific studies.
Before taking on his role at Overwatch Research, Chris cultivated a robust career steeped in research and academic excellence. He has held several prestigious positions, including Visiting Scientist at both Queen's University Belfast and the University of Washington, which has allowed him to collaborate with some of the brightest minds in his field. His extensive experience has helped to ground him in both practical and theoretical aspects of biomedical sciences, particularly in the realm of cancer research.
Education and Achievements
Chris Armstrong's academic journey is marked by impressive achievements that demonstrate his unwavering commitment to biomedical sciences and cancer research. He began his studies at Bangor Grammar School, where he laid a strong foundation for his future academic pursuits. He subsequently earned a Bachelor of Science (B.Sc.) degree with First Class Honours in Biomedical Sciences from Queen's University Belfast. This rigorous undergraduate program not only equipped him with a deep understanding of biological sciences but also ignited his passion for researching complex medical issues, particularly prostate cancer.
Pursuing his academic interests further, Chris continued at Queen's University Belfast and earned a Doctor of Philosophy (Ph.D.) in Prostate Cancer Research. This advanced degree not only highlights his expertise in this specific area but also underscores his ability to engage in high-level research that contributes to the broader scientific community. Chris's doctoral studies focused on innovative approaches to understanding and treating prostate cancer, showcasing his dedication to advancing medical knowledge and patient care.
In addition to his academic credentials, Chris has received recognition for his contributions to cancer research, serving as the Prostate Cancer UK Travelling Prize Fellow at Queen's University Belfast. This notable fellowship afforded him unique opportunities to expand his research initiatives and collaborate with various healthcare institutions, further solidifying his reputation in the field.
Notable Contributions and Affiliations
Throughout his career, Chris has held various pivotal roles that have enriched his experience and expertise. As a former Postdoctoral Researcher and PhD Student at Queen's University Belfast, he delved deeply into the intricacies of prostate cancer, collaborating with leading experts and contributing valuable insights to ongoing research initiatives. His time as a Visiting Scientist at both Queen's University Belfast and the University of Washington has enabled him to share knowledge, learn from others, and engage in groundbreaking projects that propel the field of medical science forward.
In forming Overwatch Research, Chris has taken on the challenge of translating his academic knowledge into impactful technological solutions. Under his leadership, the organization is at the forefront of finding ways to minimize error in medical research, making significant strides toward enhanced reliability in scientific findings. This focus not only reflects Chris's ambition to innovate but also demonstrates his firm commitment to improving the research landscape and ultimately, patient outcomes.
Chris Armstrong continues to inspire others in the field of biomedical research with his entrepreneurial spirit, innovative thinking, and deep knowledge of cancer science. His contributions thus far have laid a strong foundation for future advancements in both research and technology, positioning him as a leading figure in the integration of software solutions within medical research.
